| Azacitidine and venetoclax in previously untreated acute myeloid leukemia CD DiNardo, BA Jonas, V Pullarkat, MJ Thirman, JS Garcia, AH Wei, ... New England Journal of Medicine 383 (7), 617-629, 2020 | 1799 | 2020 |
| CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow O Jaksic, MM Kardum Paro, I Kardum Skelin, R Kusec, V Pejsa, B Jaksic Blood 103 (5), 1968-1969, 2004 | 69 | 2004 |
| Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis M Lucijanic, I Veletic, D Rahelic, V Pejsa, D Cicic, M Skelin, A Livun, ... Wiener klinische Wochenschrift 130, 126-133, 2018 | 35 | 2018 |
| Elevated Neutrophil–to–lymphocyte-ratio and platelet–to–lymphocyte ratio in myelofibrosis: Inflammatory biomarkers or representatives of myeloproliferation itself? M Lucijanic, D Cicic, T Stoos-Veic, V Pejsa, J Lucijanic, AF Dzankic, ... Anticancer research 38 (5), 3157-3163, 2018 | 32 | 2018 |
| Guidelines for diagnosis and treatment of chronic lymphocytic leukemia. Krohem B-Cll 2017 B Jakšić, V Pejša, S Ostojić-Kolonić, I Kardum-Skelin, S Bašić-Kinda, ... Acta Clinica Croatica 57 (1.), 190-215, 2018 | 29 | 2018 |
| The degree of anisocytosis predicts survival in patients with primary myelofibrosis M Lucijanic, V Pejsa, O Jaksic, Z Mitrovic, C Tomasovic-Loncaric, ... Acta haematologica 136 (2), 98-100, 2016 | 26 | 2016 |
| Dijagnostika i liječenje limfoma–drugi hrvatski konsenzus I Aurer, S Gašparov, M Kralik, A Balenović, D Huić, F Šantek, ... Liječnički vjesnik 135 (3-4), 0-0, 2013 | 26* | 2013 |
| Bone marrow renin-angiotensin system expression in polycythemia vera and essential thrombocythemia depends on JAK2 mutational status MM Vrsalovic, V Pejsa, TS Veic, SO Kolonic, R Ajdukovic, V Haris, ... Cancer biology & therapy 6 (9), 1430-1432, 2007 | 25 | 2007 |
| The relevance of multidrug resistance-associated P-glycoprotein expression in the treatment response of B-cell chronic lymphocytic leukemia I Svoboda-Beusan, R Kusec, K Bendelja, I Tudoric-Ghemo, B Jaksic, ... Haematologica 85 (12), 1261-1267, 2000 | 25 | 2000 |
| Rituximab with dose-adjusted EPOCH as first-line treatment in patients with highly aggressive diffuse large B-cell lymphoma and autologous stem cell transplantation in selected … V Pejša, Ž Prka, M Lucijanić, Z Mitrović, M Piršić, O Jakšić, R Ajduković, ... Croatian medical journal 58 (1), 40-48, 2017 | 24 | 2017 |
| Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia KW Pratz, P Panayiotidis, C Recher, X Wei, BA Jonas, P Montesinos, ... Blood cancer journal 12 (4), 71, 2022 | 19 | 2022 |
| Health-related quality of life in Croatian general population and multiple myeloma patients assessed by the EORTC QLQ-C30 and EORTC QLQ-MY20 questionnaires SL Ficko, V Pejsa, V Zadnik Radiology and oncology 53 (3), 337-347, 2019 | 17 | 2019 |
| High absolute basophil count is a powerful independent predictor of inferior overall survival in patients with primary myelofibrosis M Lucijanic, A Livun, T Stoos-Veic, V Pejsa, O Jaksic, D Cicic, J Lucijanic, ... Hematology 23 (4), 201-207, 2018 | 15 | 2018 |
| The accuracy of fine needle aspiration cytology and flow cytometry in evaluation of nodal and extranodal sites in patients with suspicion of lymphoma P Šenjug, K Trutin Ostović, Z Miletić, Č Tomasović Lončarić, T Štoos-Veić, ... Collegium antropologicum 34 (1), 131-137, 2010 | 15 | 2010 |
| Canonical Wnt/β-catenin signaling pathway is dysregulated in patients with primary and secondary myelofibrosis M Lucijanic, A Livun, C Tomasovic-Loncaric, T Stoos-Veic, V Pejsa, ... Clinical Lymphoma Myeloma and Leukemia 16 (9), 523-526, 2016 | 14 | 2016 |
| Heat shock protein 27 (HSP27/HSPB1) expression is increased in patients with primary and secondary myelofibrosis and may be affecting their survival M Lucijanic, A Livun, KM Tupek, T Stoos-Veic, G Aralica, I Gecek, V Pejsa, ... Leukemia & lymphoma 58 (10), 2497-2500, 2017 | 13 | 2017 |
| Higher serum uric acid is associated with higher risks of thrombosis and death in patients with primary myelofibrosis M Lucijanic, I Krecak, D Galusic, M Sedinic, H Holik, V Perisa, ... Wiener klinische Wochenschrift, 1-7, 2021 | 12 | 2021 |
| The use of peripherally inserted central catheter (PICC) in patients with hematological malignancies–a single center experience Z Mitrović, I Komljenović, O Jakšić, Ž Prka, S Šestan Crnek, ... Liječnički vjesnik 136 (5-6), 0-0, 2014 | 12 | 2014 |
| Smjernice Hrvatskog društva za hematologiju HLZ-a i KROHEM-a za zbrinjavanje anemije uzrokovane manjkom željeza I Radman, M Vodanović, I Mandac-Rogulj, J Roganović, T Valković, ... Liječnički vjesnik 141 (1-2), 1-13, 2019 | 11 | 2019 |
| Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis M Lucijanic, Z Mitrovic, D Cicic, Z Prka, V Pejsa, A Livun, T Stoos-Veic, ... International journal of hematology 107, 166-172, 2018 | 11 | 2018 |
